NO861802L - Nye derivater av tieno(2,3-d)imidazoler og fremgangsmaate til deres fremstilling. - Google Patents
Nye derivater av tieno(2,3-d)imidazoler og fremgangsmaate til deres fremstilling.Info
- Publication number
- NO861802L NO861802L NO861802A NO861802A NO861802L NO 861802 L NO861802 L NO 861802L NO 861802 A NO861802 A NO 861802A NO 861802 A NO861802 A NO 861802A NO 861802 L NO861802 L NO 861802L
- Authority
- NO
- Norway
- Prior art keywords
- general formula
- thieno
- compounds
- hydrogen
- mmol
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 10
- 150000002460 imidazoles Chemical class 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 28
- 229910052739 hydrogen Inorganic materials 0.000 claims description 26
- 239000001257 hydrogen Substances 0.000 claims description 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 150000002431 hydrogen Chemical class 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 7
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 5
- 230000002496 gastric effect Effects 0.000 claims description 5
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 150000004967 organic peroxy acids Chemical class 0.000 claims description 3
- 230000028327 secretion Effects 0.000 claims description 3
- 208000007107 Stomach Ulcer Diseases 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 208000000718 duodenal ulcer Diseases 0.000 claims description 2
- 238000011321 prophylaxis Methods 0.000 claims description 2
- 238000011282 treatment Methods 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 85
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 54
- 239000000243 solution Substances 0.000 description 50
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 32
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 32
- 239000013078 crystal Substances 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 229910052938 sodium sulfate Inorganic materials 0.000 description 19
- 235000011152 sodium sulphate Nutrition 0.000 description 19
- 238000003756 stirring Methods 0.000 description 19
- 239000012074 organic phase Substances 0.000 description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 11
- 238000000354 decomposition reaction Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 8
- 229960000583 acetic acid Drugs 0.000 description 8
- 239000012043 crude product Substances 0.000 description 8
- 239000012362 glacial acetic acid Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 7
- -1 methoxy, ethoxy, propyloxy, isopropyloxy, butyloxy, tert-butyloxy Chemical group 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- GTPCKOLSHLCFEA-UHFFFAOYSA-N 1-(2-sulfanylidene-1,3-dihydrothieno[2,3-d]imidazol-5-yl)ethanone Chemical compound N1C(=S)NC2=C1C=C(C(=O)C)S2 GTPCKOLSHLCFEA-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WGCQNQVBMANWKZ-UHFFFAOYSA-N 1,3-dihydrothieno[2,3-d]imidazole-2-thione Chemical compound C1=CSC2=C1NC(=S)N2 WGCQNQVBMANWKZ-UHFFFAOYSA-N 0.000 description 3
- IUEOFALQUTYSOZ-UHFFFAOYSA-N 2-acetamido-5-methylthiophene-3-carboxylic acid Chemical compound CC(=O)NC=1SC(C)=CC=1C(O)=O IUEOFALQUTYSOZ-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010907 mechanical stirring Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 3
- HHHNIUPEIAJYKY-UHFFFAOYSA-N 1-(5-chloro-4-nitrothiophen-2-yl)ethanone Chemical compound CC(=O)C1=CC([N+]([O-])=O)=C(Cl)S1 HHHNIUPEIAJYKY-UHFFFAOYSA-N 0.000 description 2
- YZFJCIKYUVSBMC-UHFFFAOYSA-N 1-[2-(pyridin-2-ylmethylsulfanyl)-1h-thieno[2,3-d]imidazol-5-yl]ethanone Chemical compound N=1C=2SC(C(=O)C)=CC=2NC=1SCC1=CC=CC=N1 YZFJCIKYUVSBMC-UHFFFAOYSA-N 0.000 description 2
- LCJDHJOUOJSJGS-UHFFFAOYSA-N 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridin-1-ium;chloride Chemical compound Cl.COC1=C(C)C=NC(CCl)=C1C LCJDHJOUOJSJGS-UHFFFAOYSA-N 0.000 description 2
- PBDFBZPTRXMFBL-UHFFFAOYSA-N 2-(chloromethyl)-4-methoxypyridine;hydrochloride Chemical compound Cl.COC1=CC=NC(CCl)=C1 PBDFBZPTRXMFBL-UHFFFAOYSA-N 0.000 description 2
- JPMRGPPMXHGKRO-UHFFFAOYSA-N 2-(chloromethyl)pyridine hydrochloride Chemical compound Cl.ClCC1=CC=CC=N1 JPMRGPPMXHGKRO-UHFFFAOYSA-N 0.000 description 2
- PBEKICYGTPGKQJ-UHFFFAOYSA-N 2-[(4-methoxypyridin-2-yl)methylsulfanyl]-1h-thieno[2,3-d]imidazole Chemical compound COC1=CC=NC(CSC=2NC=3C=CSC=3N=2)=C1 PBEKICYGTPGKQJ-UHFFFAOYSA-N 0.000 description 2
- AAMPZAKQBGPQRB-UHFFFAOYSA-N 2-[(4-methoxypyridin-2-yl)methylsulfanyl]-5-methyl-1h-thieno[2,3-d]imidazole Chemical compound COC1=CC=NC(CSC=2NC=3C=C(C)SC=3N=2)=C1 AAMPZAKQBGPQRB-UHFFFAOYSA-N 0.000 description 2
- UDPVHRDLHAHNEN-UHFFFAOYSA-N 2-acetamido-5-methylthiophene-3-carbonyl azide Chemical compound C(C)(=O)NC=1SC(=CC=1C(=O)N=[N+]=[N-])C UDPVHRDLHAHNEN-UHFFFAOYSA-N 0.000 description 2
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 2
- RGKDHXNELVBZTN-UHFFFAOYSA-N 5-methyl-1,3-dihydrothieno[2,3-d]imidazol-2-one Chemical compound N1C(=O)NC2=C1C=C(C)S2 RGKDHXNELVBZTN-UHFFFAOYSA-N 0.000 description 2
- POELACIUTQYWAA-UHFFFAOYSA-N 5-methyl-1,3-dihydrothieno[2,3-d]imidazole-2-thione Chemical compound N1C(=S)NC2=C1C=C(C)S2 POELACIUTQYWAA-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 description 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- WZDXMQDZTNEYND-UHFFFAOYSA-N methyl 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-1H-thieno[2,3-d]imidazole-5-carboxylate Chemical compound COC1=C(C(=NC=C1C)CSC1=NC2=C(N1)SC(=C2)C(=O)OC)C WZDXMQDZTNEYND-UHFFFAOYSA-N 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- TWLVBDIMPJJOPK-UHFFFAOYSA-N 1,3-dihydrothieno[2,3-d]imidazol-2-one Chemical compound S1C=CC2=C1N=C(O)N2 TWLVBDIMPJJOPK-UHFFFAOYSA-N 0.000 description 1
- ONYOSWJTGVFPDJ-UHFFFAOYSA-N 1-(5-amino-4-nitrothiophen-2-yl)ethanone Chemical compound CC(=O)C1=CC([N+]([O-])=O)=C(N)S1 ONYOSWJTGVFPDJ-UHFFFAOYSA-N 0.000 description 1
- HTZGPEHWQCRXGZ-UHFFFAOYSA-N 1-(5-chlorothiophen-2-yl)ethanone Chemical compound CC(=O)C1=CC=C(Cl)S1 HTZGPEHWQCRXGZ-UHFFFAOYSA-N 0.000 description 1
- CKVLPHALZNRUNX-UHFFFAOYSA-N 1-[2-(pyridin-2-ylmethylsulfinyl)-1h-thieno[2,3-d]imidazol-5-yl]ethanone Chemical compound N=1C=2SC(C(=O)C)=CC=2NC=1S(=O)CC1=CC=CC=N1 CKVLPHALZNRUNX-UHFFFAOYSA-N 0.000 description 1
- UDXHGHLOEUBPKU-UHFFFAOYSA-N 1-[2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-1h-thieno[2,3-d]imidazol-5-yl]ethanone Chemical compound COC1=C(C)C=NC(CSC=2NC=3C=C(SC=3N=2)C(C)=O)=C1C UDXHGHLOEUBPKU-UHFFFAOYSA-N 0.000 description 1
- FLNFMRJFKPRYDP-UHFFFAOYSA-N 1-[2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1h-thieno[2,3-d]imidazol-5-yl]ethanone Chemical compound COC1=C(C)C=NC(CS(=O)C=2NC=3C=C(SC=3N=2)C(C)=O)=C1C FLNFMRJFKPRYDP-UHFFFAOYSA-N 0.000 description 1
- LCEPWJQAFTVDBM-UHFFFAOYSA-N 1-[2-[(4-methoxypyridin-2-yl)methylsulfanyl]-1H-thieno[2,3-d]imidazol-5-yl]ethanone Chemical compound C(C)(=O)C1=CC2=C(NC(=N2)SCC2=NC=CC(=C2)OC)S1 LCEPWJQAFTVDBM-UHFFFAOYSA-N 0.000 description 1
- QHDBBIPXPYXAMX-UHFFFAOYSA-N 1-[2-[(4-methoxypyridin-2-yl)methylsulfinyl]-1H-thieno[2,3-d]imidazol-5-yl]ethanone Chemical compound C(C)(=O)C1=CC2=C(NC(=N2)S(=O)CC2=NC=CC(=C2)OC)S1 QHDBBIPXPYXAMX-UHFFFAOYSA-N 0.000 description 1
- UODFFWGYSJVFCZ-UHFFFAOYSA-N 2-(chloromethyl)-4-methoxypyridine Chemical compound COC1=CC=NC(CCl)=C1 UODFFWGYSJVFCZ-UHFFFAOYSA-N 0.000 description 1
- NJWIMFZLESWFIM-UHFFFAOYSA-N 2-(chloromethyl)pyridine Chemical compound ClCC1=CC=CC=N1 NJWIMFZLESWFIM-UHFFFAOYSA-N 0.000 description 1
- IYXVELBVNUVOFD-UHFFFAOYSA-N 2-(pyridin-2-ylmethylsulfanyl)-1h-thieno[2,3-d]imidazole Chemical compound N=1C=2C=CSC=2NC=1SCC1=CC=CC=N1 IYXVELBVNUVOFD-UHFFFAOYSA-N 0.000 description 1
- IUUSEDKQXRCIAR-UHFFFAOYSA-N 2-(pyridin-2-ylmethylsulfinyl)-1h-thieno[2,3-d]imidazole Chemical compound N=1C=2SC=CC=2NC=1S(=O)CC1=CC=CC=N1 IUUSEDKQXRCIAR-UHFFFAOYSA-N 0.000 description 1
- FLCSTERSQVYNNM-UHFFFAOYSA-N 2-[(4-methoxypyridin-2-yl)methylsulfinyl]-5-methyl-1H-thieno[2,3-d]imidazole Chemical compound CC1=CC2=C(NC(=N2)S(=O)CC2=NC=CC(=C2)OC)S1 FLCSTERSQVYNNM-UHFFFAOYSA-N 0.000 description 1
- FGJRZHOLONLGIM-UHFFFAOYSA-N 3-acetyl-5-methyl-1H-thieno[2,3-d]imidazol-2-one Chemical compound C(C)(=O)N1C(NC2=C1SC(=C2)C)=O FGJRZHOLONLGIM-UHFFFAOYSA-N 0.000 description 1
- AWJMEGWVHAVOJO-UHFFFAOYSA-N 5-methyl-2-(pyridin-2-ylmethylsulfanyl)-1h-thieno[2,3-d]imidazole Chemical compound N=1C=2SC(C)=CC=2NC=1SCC1=CC=CC=N1 AWJMEGWVHAVOJO-UHFFFAOYSA-N 0.000 description 1
- MYEZEXUGRRLFHP-UHFFFAOYSA-N 5-methyl-3-methylsulfinyl-2-pyridin-2-ylthieno[2,3-d]imidazole Chemical compound CS(=O)N1C=2SC(C)=CC=2N=C1C1=CC=CC=N1 MYEZEXUGRRLFHP-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical class O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- XKZIMVVOZHFEIW-UHFFFAOYSA-N methyl 2-acetamido-5-methylthiophene-3-carboxylate Chemical compound COC(=O)C=1C=C(C)SC=1NC(C)=O XKZIMVVOZHFEIW-UHFFFAOYSA-N 0.000 description 1
- GHPDMFBHITXJAZ-UHFFFAOYSA-N methyl 2-amino-5-methylthiophene-3-carboxylate Chemical compound COC(=O)C=1C=C(C)SC=1N GHPDMFBHITXJAZ-UHFFFAOYSA-N 0.000 description 1
- AJDXQZNWZYJVIO-UHFFFAOYSA-N methyl 4,5-diaminothiophene-2-carboxylate Chemical compound COC(=O)C1=CC(N)=C(N)S1 AJDXQZNWZYJVIO-UHFFFAOYSA-N 0.000 description 1
- QNZKSILGWVCZJH-UHFFFAOYSA-N methyl 5-amino-4-nitrothiophene-2-carboxylate Chemical compound COC(=O)C1=CC([N+]([O-])=O)=C(N)S1 QNZKSILGWVCZJH-UHFFFAOYSA-N 0.000 description 1
- IJSXVHIIYIMVTM-UHFFFAOYSA-N methyl 5-chloro-4-nitrothiophene-2-carboxylate Chemical compound COC(=O)C1=CC([N+]([O-])=O)=C(Cl)S1 IJSXVHIIYIMVTM-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- RZFBEFUNINJXRQ-UHFFFAOYSA-M sodium ethyl xanthate Chemical compound [Na+].CCOC([S-])=S RZFBEFUNINJXRQ-UHFFFAOYSA-M 0.000 description 1
- HSFQBFMEWSTNOW-UHFFFAOYSA-N sodium;carbanide Chemical group [CH3-].[Na+] HSFQBFMEWSTNOW-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Resins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT136085 | 1985-05-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO861802L true NO861802L (no) | 1986-11-10 |
Family
ID=3512202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO861802A NO861802L (no) | 1985-05-07 | 1986-05-06 | Nye derivater av tieno(2,3-d)imidazoler og fremgangsmaate til deres fremstilling. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0201094A3 (cs) |
| JP (1) | JPS61254591A (cs) |
| KR (1) | KR860009021A (cs) |
| AU (1) | AU582649B2 (cs) |
| CA (1) | CA1262731A (cs) |
| CS (2) | CS256397B2 (cs) |
| DD (1) | DD258608A1 (cs) |
| DK (1) | DK208086A (cs) |
| ES (1) | ES8706689A1 (cs) |
| FI (1) | FI861772A (cs) |
| HU (1) | HU194244B (cs) |
| NO (1) | NO861802L (cs) |
| NZ (1) | NZ216054A (cs) |
| SU (1) | SU1456018A3 (cs) |
| ZA (1) | ZA863354B (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU580042B2 (en) * | 1984-03-22 | 1988-12-22 | Bresatec Limited | Non-radioactive biological probes |
| ES2032394T3 (es) * | 1986-02-20 | 1993-02-16 | Hoechst Aktiengesellschaft | Procedimiento para preparar derivados de tienoimidazol sustituidos. |
| WO1987005296A1 (en) * | 1986-03-07 | 1987-09-11 | Pfizer Inc. | 2-[(2-pyridyl)methylsulfinyl]thienoimidazoles and related compounds as antiulcer agents |
| CA1256109A (en) * | 1986-09-10 | 1989-06-20 | Franz Rovenszky | Process for the preparation of derivatives of 4, 5-dihydrooxazoles |
| DE3639926A1 (de) * | 1986-11-22 | 1988-06-01 | Hoechst Ag | Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer |
| DE3723327A1 (de) * | 1987-07-15 | 1989-02-02 | Hoechst Ag | Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen |
| AU622866B2 (en) * | 1987-07-21 | 1992-04-30 | Hoechst Aktiengesellschaft | Substituted thienoimidazole derivatives, processes for their preparation, pharmaceutical formulations containing them and their use as gastric acid secretion inhibitors |
| IT1222412B (it) * | 1987-07-31 | 1990-09-05 | Chiesi Farma Spa | Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono |
| FI89602C (fi) * | 1987-08-15 | 1993-10-25 | Hoechst Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara substituerade tienoimidazolderivat |
| DE3851133D1 (de) * | 1987-11-13 | 1994-09-22 | Hoechst Ag | Substituierte Thienoimidazol-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Magensäuresekretionshemmer. |
| SE508669C2 (sv) * | 1996-04-26 | 1998-10-26 | Astra Ab | Nytt förfarande |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| ES2032394T3 (es) * | 1986-02-20 | 1993-02-16 | Hoechst Aktiengesellschaft | Procedimiento para preparar derivados de tienoimidazol sustituidos. |
| WO1987005296A1 (en) * | 1986-03-07 | 1987-09-11 | Pfizer Inc. | 2-[(2-pyridyl)methylsulfinyl]thienoimidazoles and related compounds as antiulcer agents |
| DE3639926A1 (de) * | 1986-11-22 | 1988-06-01 | Hoechst Ag | Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer |
-
1986
- 1986-04-28 FI FI861772A patent/FI861772A/fi not_active Application Discontinuation
- 1986-04-29 CA CA000507909A patent/CA1262731A/en not_active Expired
- 1986-05-05 ZA ZA863354A patent/ZA863354B/xx unknown
- 1986-05-05 NZ NZ216054A patent/NZ216054A/xx unknown
- 1986-05-06 DK DK208086A patent/DK208086A/da not_active Application Discontinuation
- 1986-05-06 JP JP61102219A patent/JPS61254591A/ja active Pending
- 1986-05-06 AU AU57164/86A patent/AU582649B2/en not_active Ceased
- 1986-05-06 HU HU861865A patent/HU194244B/hu not_active IP Right Cessation
- 1986-05-06 KR KR1019860003506A patent/KR860009021A/ko not_active Application Discontinuation
- 1986-05-06 SU SU864027477A patent/SU1456018A3/ru active
- 1986-05-06 DD DD86289990A patent/DD258608A1/de not_active IP Right Cessation
- 1986-05-06 NO NO861802A patent/NO861802L/no unknown
- 1986-05-07 EP EP86106232A patent/EP0201094A3/de not_active Withdrawn
- 1986-05-07 ES ES554732A patent/ES8706689A1/es not_active Expired
- 1986-05-07 CS CS863316A patent/CS256397B2/cs unknown
- 1986-09-17 CS CS866700A patent/CS256400B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS256397B2 (en) | 1988-04-15 |
| KR860009021A (ko) | 1986-12-19 |
| DD258608A1 (de) | 1988-07-27 |
| AU582649B2 (en) | 1989-04-06 |
| FI861772A (fi) | 1986-11-08 |
| DK208086D0 (da) | 1986-05-06 |
| CS331686A2 (en) | 1987-08-13 |
| HU194244B (en) | 1988-01-28 |
| NZ216054A (en) | 1988-10-28 |
| ES8706689A1 (es) | 1987-07-01 |
| ES554732A0 (es) | 1987-07-01 |
| SU1456018A3 (ru) | 1989-01-30 |
| HUT40667A (en) | 1987-01-28 |
| CS256400B2 (cs) | 1988-04-15 |
| FI861772A0 (fi) | 1986-04-28 |
| AU5716486A (en) | 1986-11-13 |
| EP0201094A2 (de) | 1986-12-17 |
| JPS61254591A (ja) | 1986-11-12 |
| CS670086A2 (en) | 1987-08-13 |
| EP0201094A3 (de) | 1988-04-27 |
| ZA863354B (en) | 1986-12-30 |
| DK208086A (da) | 1986-11-08 |
| CA1262731A (en) | 1989-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4435406A (en) | Imidazole derivatives | |
| CA2156078C (en) | New imidazopyridines | |
| US4520025A (en) | Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses | |
| EP0080602A1 (de) | Substituierte Benzimidazole, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel | |
| PL147842B1 (en) | Method of obtaining novel pyroisobenzimidazoles | |
| CZ292335B6 (cs) | Tetrahydropyridoethery, jejich použití a farmaceutický prostředek | |
| US4560693A (en) | [1,3]-Dioxolo[4,5-f]benzimidazoles and [1,4]-dioxino[2,3-f]benzimidazoles | |
| NO861802L (no) | Nye derivater av tieno(2,3-d)imidazoler og fremgangsmaate til deres fremstilling. | |
| NO164473B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-pyridylmethyl-thio- og -sulfinylbenzimidazoler. | |
| NO311672B1 (no) | Nye forbindelser, farmasöytisk preparat inneholdende slike forbindelser, deres anvendelser, og fremgangsmåter for deresfremstilling | |
| AU596869B2 (en) | 2-(thio-linked)-pyridine-5-(4,5-dihydro-2-oxazolyl)-(thieno( 2,3-d)-imidazoles and -benzimidazoles), a process for their preparation, and their use | |
| CA1103245A (en) | Process for the manufacture of novel oxadiazolopyrimidine derivatives | |
| CA1287631C (en) | 5-substituted-6-aminopyrimidine derivatives, composition and uses | |
| US5037830A (en) | Novel thiouracyl derivatives, pharmaceutical compositions containing them and process for preparing same | |
| NO151387B (no) | Innstillingsinnretning for en elektronisk digitalindikator | |
| US5192774A (en) | Substituted acetamide derivatives, process for their preparation and antiulcer drug containing same | |
| CA1247623A (en) | Derivatives of 2-(2-thienyl)-imidazo-¬4,5-b|- pyridines and their pharmaceutically acceptable salts and a process for the preparation thereof | |
| EP0147691B1 (en) | Antihypertensive 3-aryl-1,2-benzisoxazolsulfonyl and-sulfinyl-alkanoic acids, a process for their preparation and their use for the preparation of medicaments | |
| JPH10505331A (ja) | ベンジルイミダゾピリジン | |
| EP0200777A1 (de) | Neue aminoverbindungen, verfahren zu ihrer herstellung, ihre anwendung und sie enthaltende arzneimittel | |
| KR100487029B1 (ko) | 신규화합물 | |
| KR900008550B1 (ko) | 피라졸로[3,4-b]피리딘 유도체의 제조 방법 | |
| FR2640975A1 (cs) | ||
| DK141406B (da) | Analogifremgangsmåde til fremstilling af 4H-thieno (3,2-b) (1) benzazepinderivater eller syreadditionssalte deraf. | |
| KR20150088301A (ko) | 산 분비 억제제로서의 피리돈 유도체 및 이의 제조 방법 |